Psst: These Two Biotech Plays Look Like Great Under-the-Radar Deals
Let’s check out two biopharma plays that scream ‘growth at a reasonable price.’
Let’s check out two biopharma plays that scream ‘growth at a reasonable price.’
Delta Air Lines profit cut, Lumentum’s ‘sold out’ market, and other headlines moving the market this morning.
As biotech is getting hit and we’re seeing ETF-driven selling, I smell opportunity for sharp traders.
Yields remain in the driver’s seat, with bond shorts at extremes and a light week on the calendar.
Anthropic’s IPO timing, Boeing averts strike and other headlines moving the market this morning.
Let’s check on calls to release diesel reserves, the buildup of troops in the Middle East, crude prices and … why the banks could rally.
OpenAI’s DevDay, Oura postpones IPO, Boeing’s 737 MAX 10 delay, and other headlines moving the market this morning.
We’ve already got a market-relevant impact on tariffs, but what are the other main points of contention as the “G2” gather?
September Flash PMI, Zuckerberg’s Meta Connect keynote, and other headlines are moving the market this morning.
Big banks like Wells Fargo, Bank of America, and JPMorgan Chase slid on Tuesday as did financial services ETFs. Let’s see what’s going on.